Thakur Tanvee, Frey Meredith, Chewning Betty
Social and Administrative Sciences in Pharmacy Division, University of Wisconsin-Madison School of Pharmacy, United States.
PGY2 Pharmacy Resident - Ambulatory Care Setting, University of Iowa Hospitals and Clinics, United States.
Explor Res Clin Soc Pharm. 2021 May 29;2:100030. doi: 10.1016/j.rcsop.2021.100030. eCollection 2021 Jun.
Prescription opioids contribute to 40% of opioid overdose deaths in the United States. Healthcare professionals (HCPs) play an important role in mitigating the prescription opioid epidemic by appropriate opioid prescribing and patient education. Yet, little empirical literature addresses pharmacist (and other HCP) communication with patients related to risks of opioid use associated with dependence, misuse, and overdose. Nor is there much research on the barriers and facilitators which affect whether and how much opioid-related information is discussed. This commentary, based on an extensive literature search, seeks to inform future communication, education, and research agendas by describing (1) topics commonly discussed or excluded from opioid medication counseling, (2) patient and HCP perceptions regarding opioid medication communication, and (3) barriers and facilitators to opioid risk communication. Based on this literature, recommendations are provided for opioid counseling practices, pharmacist education, and research agendas.
在美国,处方类阿片药物导致了40%的阿片类药物过量死亡。医疗保健专业人员(HCPs)通过合理开具阿片类药物处方和对患者进行教育,在缓解处方类阿片药物流行方面发挥着重要作用。然而,很少有实证文献涉及药剂师(以及其他医疗保健专业人员)与患者就与依赖、滥用和过量使用相关的阿片类药物使用风险进行的沟通。对于影响是否以及讨论多少阿片类药物相关信息的障碍和促进因素,也没有太多研究。本评论基于广泛的文献检索,旨在通过描述(1)阿片类药物用药咨询中通常讨论或排除的主题,(2)患者和医疗保健专业人员对阿片类药物用药沟通的看法,以及(3)阿片类药物风险沟通的障碍和促进因素,为未来的沟通、教育和研究议程提供信息。基于这些文献,针对阿片类药物咨询实践、药剂师教育和研究议程提出了建议。